Breztri is an inhaler used every day to help control COPD and asthma. It combines three medicines: a steroid that calms swelling in the airways and two medicines that relax the muscles around them so air moves more easily. It is not a rescue inhaler for sudden breathing trouble.
Every report comes from a Lived member, sent anonymously.
Have you tried Breztri (Budesonide / Glycopyrrolate / Formoterol) for COPD?
Breztri Aerosphere is a prescription inhaler that combines three medicines in one device: budesonide, an inhaled corticosteroid (steroid) that calms inflammation in the airways; glycopyrrolate, an anticholinergic bronchodilator; and formoterol, a long-acting beta-2 agonist (LABA) bronchodilator. It is a maintenance inhaler, used every morning and evening to keep breathing symptoms under control and lower the chance of flare-ups. It is approved for adults with COPD (chronic obstructive pulmonary disease, which includes emphysema and chronic bronchitis). In a year-long trial of people with moderate to very severe COPD who had had a flare-up in the previous year, flare-ups needing steroid tablets, antibiotics or hospital care were about 24% less frequent than with an inhaler containing only the two bronchodilators, and about 13% less frequent than with a steroid plus formoterol inhaler. It is also approved for maintenance treatment of asthma in adults and children 12 and older, using a separate strength with more glycopyrrolate. In the asthma trials, people whose asthma remained poorly controlled on a steroid plus long-acting bronchodilator inhaler had better lung function after switching to Breztri; severe asthma attacks were somewhat less frequent overall, though that difference was not clear-cut in every comparison. Because it holds three medicines, Breztri is usually a step up for people whose symptoms or flare-ups continue on a one- or two-medicine inhaler, rather than a first treatment. It is not a rescue inhaler for sudden breathing trouble, and it is not approved for children under 12.
In both COPD and asthma, airways narrow for two main reasons: the lining becomes inflamed and swollen, and the bands of muscle around the airways tighten. Breztri works on both. Budesonide acts on the airway lining, damping down the inflammatory cells and chemical signals that cause swelling and extra mucus. This effect builds over days to weeks and is the main reason inhaled steroids reduce flare-ups. Glycopyrrolate blocks acetylcholine, a nerve signal that tells airway muscle to contract. Formoterol stimulates beta-2 receptors on the same muscle, which tells it to relax. Using two bronchodilators that open the airways by different routes gives more relief than either one alone, and both last for many hours, which is why the inhaler is used twice a day. Formoterol starts working quickly: in trials, lung function measurably improved within about five minutes of the first dose. Even so, Breztri is not meant for sudden symptoms, because its total daily dose is fixed and extra puffs add risk without adding the right kind of relief.
Breztri is a pressurized spray inhaler (a metered-dose inhaler). The usual dose for both COPD and asthma is 2 puffs in the morning and 2 puffs in the evening, and no more than that. The two conditions use different strengths: each puff of the COPD inhaler contains 160 mcg budesonide, 9 mcg glycopyrrolate and 4.8 mcg formoterol, while the asthma strength has 18 mcg glycopyrrolate per puff. It is worth checking that the pharmacy label matches the condition being treated. Shake the inhaler before each puff. A new inhaler must be primed with 4 sprays into the air, away from the face, before first use, and re-primed with 2 sprays if it has not been used for more than 7 days, has been dropped, or after its weekly rinse. After each dose, rinse the mouth with water and spit it out; this lowers the chance of thrush, a fungal infection of the mouth and throat. If a dose is missed, take it as soon as remembered and take the next one at the usual time; do not double up. The dose counter shows how many puffs remain. Throw the inhaler away when the counter reaches zero or three months after opening its foil pouch, whichever comes first. Everyone using Breztri should also have a separate quick-relief (rescue) inhaler, such as albuterol, and carry it at all times. That inhaler, not extra Breztri puffs, is what treats sudden wheezing or breathlessness.
In the COPD trials, the most common side effects were colds and other upper respiratory infections, flu, sinus infections, cough, back pain, muscle spasms, urinary tract infections, diarrhea and hoarseness. In the asthma trials, the most common were sore throat and runny nose, pneumonia and headache. Formoterol can cause shakiness, nervousness or a pounding or fast heartbeat, and it can raise blood sugar and lower potassium, which matters more for people with diabetes or heart rhythm problems. Thrush shows up as white patches, soreness or a cottony feeling in the mouth or throat. Rinsing after each dose helps prevent it, and it can usually be treated with antifungal medicine while Breztri continues. The steroid component raises the risk of pneumonia, especially in COPD. In a year-long COPD trial, about 4 in 100 people using Breztri had confirmed pneumonia, compared with about 2 in 100 on a similar inhaler without the steroid. Because pneumonia and a COPD flare can look alike, fever, chills, more mucus, a change in mucus color or a worsening cough should be reported to the care team. Glycopyrrolate can worsen two conditions that depend on how muscles respond to nerve signals. Eye pain, blurred vision, seeing halos around lights or a red eye can signal a sudden rise in eye pressure (acute narrow-angle glaucoma), which can damage vision; call the prescriber right away and before the next dose. Difficulty passing urine, a weak stream or painful urination can signal urinary retention; stop Breztri and call the prescriber right away. Chest pain or a fast or irregular heartbeat also calls for prompt contact. Rarely, an inhaler makes the airways tighten instead of open. If breathing suddenly gets worse right after a puff, use the rescue inhaler, stop Breztri and contact the prescriber right away; get emergency care if breathing does not quickly improve. Swelling of the face, lips or tongue, or trouble breathing with hives, is a serious allergic reaction that needs emergency care.
Breztri should not be combined with any other medicine that contains a long-acting beta-2 agonist (such as salmeterol, vilanterol, olodaterol, indacaterol or another formoterol product) or an inhaled anticholinergic (such as tiotropium, umeclidinium, aclidinium or ipratropium). Many COPD and asthma inhalers contain one of these, and doubling up can lead to overdose effects on the heart and other side effects. Anyone switching to Breztri should confirm which older inhalers to stop. Beta-blockers, heart and blood pressure medicines such as propranolol or metoprolol, can blunt formoterol's effect and may trigger severe airway tightening; when one is truly needed, a prescriber may choose a type that acts mainly on the heart. Strong blockers of the liver enzyme that clears budesonide, including ritonavir (an HIV medicine), itraconazole and ketoconazole (antifungals) and clarithromycin (an antibiotic), can raise steroid levels in the body. Certain older antidepressants (monoamine oxidase inhibitors and tricyclics) and other medicines that affect heart rhythm can add to formoterol's effects on the heart, and water pills (diuretics) can deepen a drop in potassium. Tell the prescriber about heart disease, high blood pressure, seizures, thyroid disease, diabetes, osteoporosis, glaucoma or cataracts, an enlarged prostate or bladder problems, and any current infection, including tuberculosis. Inhaled steroids can make some infections harder to fight; someone who is not immune and is exposed to chickenpox or measles should let their clinician know. People moving from steroid tablets such as prednisone to Breztri need a slow, supervised taper. After long use of steroid tablets, the body's own steroid production (from the adrenal glands) may be low, and during the transition illness, injury or surgery can bring on dangerous adrenal insufficiency, with tiredness, weakness, nausea, vomiting and low blood pressure. Long-term inhaled steroid use can thin bones and raise the risk of cataracts and glaucoma, so bone and eye checks may be recommended, and growth is monitored in teenagers. For pregnancy, there are no adequate studies of the combination; large studies of inhaled budesonide have not shown an increase in birth defects, and poorly controlled asthma itself carries risks for mother and baby, so the decision is best made with the prescriber.
Breathing may feel easier soon after the first doses, because the two bronchodilators act quickly. The steroid's effect on inflammation builds more slowly over the following weeks, and the reduction in flare-ups is something that shows up over months rather than days. The inhaler works only when used every day, including on days when breathing feels fine. Rescue inhaler use is a useful gauge of control. Needing it more often than usual, finding that it works less well, or noticing that breathing problems are getting worse are signs that the condition is deteriorating; contact the care team right away, and get emergency care if breathing is severely difficult. Follow-up visits usually review symptoms, flare-ups and rescue inhaler use, and check inhaler technique, since the medicine only helps if the spray actually reaches the lungs. People on long-term treatment may also have periodic eye exams and, if at risk, bone density checks. Breztri controls COPD and asthma; it does not cure them. Do not stop it without talking to the prescriber, because symptoms can return. Any change to the plan, including stopping or switching inhalers, is best made together with the prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Breztri (Budesonide / Glycopyrrolate / Formoterol), what you've noticed, or ask the community a question.